Mechanisms of acute lung injury from blood transfusions.
Mechanisms of acute lung injury from blood transfusions.
批准号:
8845595
负责人:
MARK ROBERTS LOONEY
金额:
$39.82万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-04-01 至 2017-03-31
关键词:
AcuteAcute Lung InjuryAffectAspirinAwardBlood PlateletsBlood TransfusionBlood VesselsBone MarrowCause of DeathCellsChimera organismDataDeoxyribonucleasesDependencyDevelopmentDyesEndotheliumEventFc ReceptorHistonesHumanImageImmunologicsIn VitroInjuryInvestigationKnock-outKnockout MiceLaser MicroscopyLeadLeukocyte ElastaseLeukocytesLifeLungMHC Class I GenesMatrix MetalloproteinasesMicrocirculationMicroscopyModelingMolecularMonoclonal AntibodiesMouse ProteinMusPathogenesisPeptide HydrolasesPermeabilityPlasmaPlatelet ActivationPlatelet InhibitorsProcessProductionProteinsPulmonary EdemaReactive Oxygen SpeciesRiskRoleSeveritiesSurfaceTestingTimeTransfusionTransgenic OrganismsUnited StatesVascular PermeabilitiesWild Type Mousebaseclopidogrelextracellularin vivoinhibitor/antagonistinjuredintravital microscopyloss of function mutationlung injurymortalitymouse modelneutralizing antibodyneutrophilnovelperipheral bloodreceptorreceptor expressionspatial relationshiptirofibantwo-photon
中文摘要
描述(由申请人提供):输血的主要非感染性风险之一是输血相关急性肺损伤(TRALI)的发展,这是美国输血相关死亡率的第一大原因。我们之前在TRALI小鼠模型中表明,中性粒细胞和血小板都是产生急性肺内皮损伤、蛋白通透性和肺水肿所必需的。然而,中性粒细胞和血小板相互作用并最终导致肺损伤的机制尚不清楚。在这个应用中,我们将在三个科学目标中测试潜在的机制。在Aim 1中,我们将测试TRALI中中性粒细胞-血小板聚集体的存在,并通过使用骨髓嵌合体和从MHC i类缺失小鼠和Fcg受体敲除中分离的细胞进行体外研究来确定聚集体的分子机制。我们还将测试血小板的药理学抑制剂以及这些抑制剂可能改善肺损伤的机制。在Aim 2中,我们将通过使用中性粒细胞蛋白酶和ROS产生功能突变丧失的小鼠来确定中性粒细胞如何导致肺内皮损伤。我们假设中性粒细胞胞外陷阱(NETs)将在TRALI中形成一个血小板依赖的过程,暴露细胞外组蛋白导致肺内皮损伤。在Aim 3中,我们将使用双光子显微镜在活体小鼠肺中的新应用,对TRALI小鼠模型中中性粒细胞和血小板募集的时间序列进行成像。使用活体显微镜,我们还将确定受伤肺中中性粒细胞和血小板之间的空间关系,以及这如何影响肺微血管中NET的形成。这项研究的结果将阐明TRALI肺损伤的机制,并通过关注血小板活化和NET形成的作用,有可能确定治疗急性肺损伤的新药理学方法。
英文摘要
DESCRIPTION (provided by applicant): One of the major non-infectious risks from blood transfusions is the development of transfusion-related acute lung injury (TRALI), which is the number one cause of transfusion-related mortality in the United States. We have previously shown in a mouse model of TRALI that neutrophils and platelets are both required to produce acute lung endothelial injury, protein permeability, and pulmonary edema. However, the mechanisms by which neutrophils and platelets potentially interact and ultimately lead to lung injury are not known. In this application, we will test potential mechanisms in three scientific aims. In Aim 1, we will test for the presence of neutrophil-platelet aggregates in TRALI and determine the molecular mechanisms responsible for the aggregates by using bone marrow chimeras and in vitro studies with cells isolated from MHC Class I-null mice and Fcg receptor knockouts. We will also test pharmacologic inhibitors of platelets and the mechanisms by which these inhibitors may ameliorate lung injury. In Aim 2, we will determine how neutrophils lead to lung endothelial injury by using mice with loss of function mutations in neutrophil proteases and ROS production. We hypothesize that neutrophil extracellular traps (NETs) will be formed in TRALI in a platelet-dependent process that exposes extracellular histones leading to lung endothelial injury. In Aim 3, we will use a new application of two-photon microscopy in the live, mouse lung to image the temporal sequence of neutrophil and platelet recruitment in our mouse model of TRALI. Using intravital microscopy, we will also determine the spatial relationships between neutrophils and platelets in the injured lung and how this influences NET formation in the lung microvasculature. The results from this investigation will elucidate the mechanisms of lung injury in TRALI, and by focusing on the roles of platelet activation and NET formation it may be possible to identify novel pharmacologic approaches to treating acute lung injury.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunomodulation by splenic megakaryocytes and platelets in sepsis
-
批准号:10640199
-
项目类别:
-
资助金额:$64.38万
-
财政年份:2022
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Immunomodulation by splenic megakaryocytes and platelets in sepsis
-
批准号:10521976
-
项目类别:
-
资助金额:$62.12万
-
财政年份:2022
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Immunobiology of the normal and injured lung
-
批准号:10353875
-
项目类别:
-
资助金额:$56.6万
-
财政年份:2022
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Immunobiology of the normal and injured lung
-
批准号:10542751
-
项目类别:
-
资助金额:$93.19万
-
财政年份:2022
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
-
批准号:10490902
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2021
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
-
批准号:10365868
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2021
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms and pathogenicity of SARS-CoV-2-induced neutrophil extracellular traps
-
批准号:10676842
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2021
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms of antibody-mediated lung Injury after blood transfusion
-
批准号:10318593
-
项目类别:
-
资助金额:$57.73万
-
财政年份:2019
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Innate Immune Mechanisms of Primary Graft Dysfunction after Lung Transplantation
-
批准号:9006789
-
项目类别:
-
资助金额:$53.63万
-
财政年份:2016
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Fine-tuning the Neutrophilic Response to Pneumonia
-
批准号:9157282
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2016
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Fine-tuning the Neutrophilic Response to Pneumonia
-
批准号:9281669
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2016
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Fine-tuning the Neutrophilic Response to Pneumonia
-
批准号:9491695
-
项目类别:
-
资助金额:$45.03万
-
财政年份:2016
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms of acute lung injury from blood transfusions.
-
批准号:8646984
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2011
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Platelet and megakaryocyte biology in the normal and injured lung
-
批准号:9921452
-
项目类别:
-
资助金额:$54.24万
-
财政年份:2011
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Platelet and megakaryocyte biology in the normal and injured lung
-
批准号:9389831
-
项目类别:
-
资助金额:$54.43万
-
财政年份:2011
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms of acute lung injury from blood transfusions.
-
批准号:8450695
-
项目类别:
-
资助金额:$39.91万
-
财政年份:2011
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms of acute lung injury from blood transfusions.
-
批准号:8087774
-
项目类别:
-
资助金额:$43.26万
-
财政年份:2011
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Mechanisms of acute lung injury from blood transfusions.
-
批准号:8240457
-
项目类别:
-
资助金额:$43.26万
-
财政年份:2011
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Experimental transfusion-related acute lung injury
-
批准号:7743045
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2006
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
Experimental transfusion-related acute lung injury
-
批准号:7992429
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2006
-
负责人:MARK ROBERTS LOONEY
-
依托单位:
海外基金